Robert R Conley

Robert R Conley

UNVERIFIED PROFILE

Are you Robert R Conley?   Register this Author

Register author
Robert R Conley

Robert R Conley

Publications by authors named "Robert R Conley"

Are you Robert R Conley?   Register this Author

81Publications

724Reads

27Profile Views

Trial of Galcanezumab in Prevention of Episodic Cluster Headache.

N Engl J Med 2019 07;381(2):132-141

From the NIHR-Wellcome Trust King's Clinical Research Facility and SLaM Biomedical Research Centre, King's College London, and King's College Hospital, London (P.J.G.); the Department of Neurology, Mayo Clinic, Scottsdale, AZ (D.W.D.); the IRCCS Foundation Carlo Besta Neurologic Institute, Milan (M.L.); Eli Lilly, Indianapolis (J.N.B., T.M.O., B.A.M., C.Z., S.A.D., S.K.A., A.H.A., J.-Y.Y., R.R.C., J.M.M.); and the University of Maryland School of Medicine, Baltimore (R.R.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1813440DOI Listing
July 2019

Protecting confidentiality in human research.

Am J Psychiatry 2013 May;170(5):466-70

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas; VA North TexasHealth Care System, Dallas VAMC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2012.12050595DOI Listing
May 2013

Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra.

Front Psychiatry 2012 9;3:31. Epub 2012 Apr 9.

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fpsyt.2012.00031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321522PMC
October 2012

Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms.

Schizophr Res 2012 Feb 21;134(2-3):195-201. Epub 2011 Oct 21.

Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2011.09.028DOI Listing
February 2012

Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia.

Synapse 2012 Jan 11;66(1):29-41. Epub 2011 Oct 11.

Maryland Psychiatric Research Center, Maple and Locust Street, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.20981DOI Listing
January 2012

Researcher experiences with IRBs: a survey of members of the American College of Neuropsychopharmacology.

IRB 2011 Sep-Oct;33(5):14-20

Human Research Committee, American College of Neuropsychoparmacology.

View Article

Download full-text PDF

Source
December 2011

Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response.

Synapse 2011 Mar;65(3):215-24

Neuroscience and Cognitive Sciences, University of Maryland, Baltimore County, Catonsville 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.20838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504676PMC
March 2011

Mitochondria in the striatum of subjects with schizophrenia.

World J Biol Psychiatry 2011 Feb 10;12(1):48-56. Epub 2010 Aug 10.

Neuroscience and Cognitive Sciences, University of Maryland, Baltimore County, Catonsville, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/15622975.2010.505662DOI Listing
February 2011

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.

Neuropsychopharmacology 2010 Oct 21;35(11):2274-83. Epub 2010 Jul 21.

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npp.2010.101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939921PMC
October 2010

Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.

Compr Psychiatry 2010 May-Jun;51(3):298-302. Epub 2009 Aug 27.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.comppsych.2009.07.003DOI Listing
July 2010

Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.

Compr Psychiatry 2010 May-Jun;51(3):298-302. Epub 2009 Aug 27.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.comppsych.2009.07.003DOI Listing
July 2010

Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.

J Clin Psychiatry 2010 Mar 12;71(3):304-11. Epub 2010 Jan 12.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.08m04718yelDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607426PMC
March 2010

The cost of relapse and the predictors of relapse in the treatment of schizophrenia.

BMC Psychiatry 2010 Jan 7;10. Epub 2010 Jan 7.

US Outcomes Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-244X-10-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817695PMC
January 2010

The burden of depressive symptoms in people with schizophrenia.

Authors:
Robert R Conley

Psychiatr Clin North Am 2009 Dec;32(4):853-61

Eli Lilly and Company, US Medical Division, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psc.2009.09.001DOI Listing
December 2009

The burden of depressive symptoms in people with schizophrenia.

Authors:
Robert R Conley

Psychiatr Clin North Am 2009 Dec;32(4):853-61

Eli Lilly and Company, US Medical Division, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psc.2009.09.001DOI Listing
December 2009

The effects of galantamine on psychopathology in chronic stable schizophrenia.

Clin Neuropharmacol 2009 Mar-Apr;32(2):69-74

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0B013E31816F2795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049075PMC
September 2009

Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response.

Synapse 2009 Jun;63(6):520-30

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.20623DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770250PMC
June 2009

A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.

J Clin Psychiatry 2009 Apr 7;70(4):518-25. Epub 2009 Apr 7.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.08m04358DOI Listing
April 2009

Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia.

Am J Med Genet B Neuropsychiatr Genet 2009 Mar;150B(2):282-9

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.b.30811DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2774755PMC
March 2009

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.

Biol Psychiatry 2009 Mar 21;65(6):489-94. Epub 2008 Dec 21.

Division of Geriatric Psychiatry, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2008.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752997PMC
March 2009

The effects of galantamine on psychopathology in chronic stable schizophrenia.

Clin Neuropharmacol 2009 Mar-Apr;32(2):69-74

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0B013E31816F2795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049075PMC
September 2009

The effects of galantamine on psychopathology in chronic stable schizophrenia.

Clin Neuropharmacol 2009 Mar-Apr;32(2):69-74

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0B013E31816F2795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049075PMC
September 2009

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis.

Biol Psychiatry 2009 Mar 21;65(6):489-94. Epub 2008 Dec 21.

Division of Geriatric Psychiatry, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopsych.2008.11.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752997PMC
March 2009

The effects of galantamine on psychopathology in chronic stable schizophrenia.

Clin Neuropharmacol 2009 Mar-Apr;32(2):69-74

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0B013E31816F2795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049075PMC
September 2009

Comparison of clozapine response for inpatients in the research setting versus routine clinical practice.

Psychiatr Q 2008 Jun 24;79(2):111-9. Epub 2008 Jan 24.

Maryland Psychiatric Research Center, School of Medicine, University of Maryland-Baltimore, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11126-008-9067-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120101PMC
June 2008

Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia.

Synapse 2008 Aug;62(8):616-27

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.20534DOI Listing
August 2008

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.

Schizophr Res 2008 Aug 11;103(1-3):161-8. Epub 2008 Jun 11.

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Box 22147 Baltimore, MD 21228, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2008.04.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2547986PMC
August 2008

Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine.

Ann Clin Psychiatry 2008 Apr-Jun;20(2):71-8

Maryland Psychiatric Research Center, University of Maryland, School of Medicine, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10401230802017050DOI Listing
July 2008

Comparison of clozapine response for inpatients in the research setting versus routine clinical practice.

Psychiatr Q 2008 Jun 24;79(2):111-9. Epub 2008 Jan 24.

Maryland Psychiatric Research Center, School of Medicine, University of Maryland-Baltimore, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11126-008-9067-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120101PMC
June 2008

Maintaining informed consent validity during lengthy research protocols.

IRB 2007 Nov-Dec;29(6):1-6

University of Maryland School of Medicine, USA.

View Article

Download full-text PDF

Source
March 2008

Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia.

Synapse 2008 Aug;62(8):616-27

Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.20534DOI Listing
August 2008

Galantamine for the treatment of cognitive impairments in people with schizophrenia.

Am J Psychiatry 2008 Jan 6;165(1):82-9. Epub 2007 Nov 6.

Department of Psychiatry, University of Maryland, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2007.07050724DOI Listing
January 2008

Comparison of clozapine response for inpatients in the research setting versus routine clinical practice.

Psychiatr Q 2008 Jun 24;79(2):111-9. Epub 2008 Jan 24.

Maryland Psychiatric Research Center, School of Medicine, University of Maryland-Baltimore, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11126-008-9067-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120101PMC
June 2008

Challenge to atypical antipsychotic drug effect on cognition.

Am J Psychiatry 2007 Dec;164(12):1910-1; author reply 1911-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2007.07071086DOI Listing
December 2007

Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study.

J Clin Psychiatry 2006 Sep;67(9):1391-6

Department of Psychiatry, Dongseo Hospital, Masan, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v67n0909DOI Listing
September 2006

Clozapine underutilization and discontinuation in African Americans due to leucopenia.

Schizophr Bull 2007 Sep 14;33(5):1221-4. Epub 2006 Dec 14.

The Maryland Psychiatric Research Center, Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/schbul/sbl068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632351PMC
September 2007

Reaching for wellness in schizophrenia.

Psychiatr Clin North Am 2007 Sep;30(3):453-79

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psc.2007.04.003DOI Listing
September 2007

Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

Am J Psychiatry 2007 Sep;164(9):1404-10

Clinical Trial Center, Department of Psychiatry and Clinical Pharmacology, Busan Paik Hospital, Inje University, Busan 614-735, Republic of Korea.

View Article

Download full-text PDF

Source
http://psychiatryonline.org/doi/abs/10.1176/appi.ajp.2007.06
Publisher Site
http://dx.doi.org/10.1176/appi.ajp.2007.06071075DOI Listing
September 2007

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.

Psychiatr Q 2006 ;77(1):81-95

Maryland Psychiatric Research Center, University of Maryland, Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11126-006-7963-9DOI Listing
June 2007

Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients.

Psychopharmacol Bull 2007 ;40(1):77-97

Maryland Psychiatric Research Center in the University of Maryland School of Medicine at Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
May 2007

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia.

Schizophr Res 2007 Feb 15;90(1-3):186-97. Epub 2006 Nov 15.

Maryland Psychiatric Research Center, University of Maryland at Baltimore, School of Medicine, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2006.09.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1937504PMC
February 2007

Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study.

CNS Spectr 2006 Sep;11(9 Suppl 10):1-13; quiz 14

Glazer Medical Solutions, Menemsha, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s1092852900025748DOI Listing
September 2006

Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study.

J Clin Psychiatry 2006 Sep;67(9):1391-6

Department of Psychiatry, Dongseo Hospital, Masan, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v67n0909DOI Listing
September 2006

Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

J Clin Psychiatry 2006 Sep;67(9):1404-11

Maryland Psychiatric Research Center, University of Maryland, Baltimore 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v67n0911DOI Listing
September 2006

Plasma concentrations of high-dose olanzapine in a double-blind crossover study.

Hum Psychopharmacol 2006 Aug;21(6):393-8

Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.781DOI Listing
August 2006

Plasma concentrations of high-dose olanzapine in a double-blind crossover study.

Hum Psychopharmacol 2006 Aug;21(6):393-8

Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.781DOI Listing
August 2006

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.

Psychoneuroendocrinology 2006 Apr 28;31(3):340-6. Epub 2005 Sep 28.

Maryland Psychiatric Research Center, University of Maryland, Box 21247, Baltimore, 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psyneuen.2005.08.010DOI Listing
April 2006

Cardiovascular disease in relation to weight in deceased persons with schizophrenia.

Compr Psychiatry 2005 Nov-Dec;46(6):460-7

Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.comppsych.2005.03.007DOI Listing
March 2006

First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Drugs 2005 ;65(8):1113-38

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003495-200565080-00006DOI Listing
November 2005

Synaptic differences in the patch matrix compartments of subjects with schizophrenia: a postmortem ultrastructural study of the striatum.

Neurobiol Dis 2005 Nov;20(2):324-35

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, P.O. Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2005.03.015DOI Listing
November 2005

Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.

Isr J Psychiatry Relat Sci 2005 ;42(1):51-60

Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
October 2005

Sexuality and schizophrenia: a review.

Schizophr Bull 2004 ;30(4):767-79

Maryland Psychiatric Research Center, University of Maryland, Box 21247, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/oxfordjournals.schbul.a007130DOI Listing
July 2005

Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis.

Synapse 2005 Jun;56(4):185-97

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.20144DOI Listing
June 2005

Comparison of clozapine use in Maryland and in Victoria, Australia.

Psychiatr Serv 2005 Mar;56(3):320-3

Maryland Psyciatric Research Center, University of Maryland, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.56.3.320DOI Listing
March 2005

More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.

Stat Med 2005 Jan;24(1):11-21

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland Baltimore Medical School, Baltimore MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.1837DOI Listing
January 2005

More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk.

Stat Med 2005 Jan;24(1):11-21

Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland Baltimore Medical School, Baltimore MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/sim.1837DOI Listing
January 2005

Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.

J Clin Psychiatry 2005 Jan;66(1):80-4

Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v66n0111DOI Listing
January 2005

The heterogeneity of schizophrenia in disease states.

Schizophr Res 2004 Nov;71(1):83-95

Centers for Medicare and Medicaid Services, ORDI/REG/DBR, Mail stop C3-19-07 7500, Security Boulevard, Baltimore, MD 21244, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2003.11.008DOI Listing
November 2004

Cortisol response to buspirone in extended abstinent alcoholics.

Alcohol Alcohol 2004 Jul-Aug;39(4):287-9

Department of Psychiatry, Busan Paik Hospital 633-165 Gaegum-Dong, Busanjin-Gu, 614-735, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/alcalc/agh068DOI Listing
October 2004

The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.

J Psychopharmacol 2004 Sep;18(3):429-31

Maryland Psychiatric Research Center, University of Maryland, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/026988110401800315
Publisher Site
http://dx.doi.org/10.1177/026988110401800315DOI Listing
September 2004

Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia.

Ann Clin Psychiatry 2003 Sep-Dec;15(3-4):181-6

Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/b:acli.0000008171.90644.f8DOI Listing
August 2004

Atypical antipsychotic use in a state hospital inpatient adolescent population.

J Child Adolesc Psychopharmacol 2004 ;14(1):75-85

Maryland Psychiatric Research Center, University of Maryland, Baltimore, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/104454604773840517DOI Listing
August 2004

The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.

J Psychopharmacol 2004 Sep;18(3):429-31

Maryland Psychiatric Research Center, University of Maryland, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/026988110401800315
Publisher Site
http://dx.doi.org/10.1177/026988110401800315DOI Listing
September 2004

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.

Clin Neuropharmacol 2003 Nov-Dec;26(6):297-8

VA Capitol Healthcare Network Mental Illness Research Education and Clinical Care Center (MIRECC), Veterans Affairs, Maryland Health Care System, University of Maryland School of Medicine, Baltimore, MD 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002826-200311000-00007DOI Listing
February 2004

Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia.

Ann Clin Psychiatry 2003 Sep-Dec;15(3-4):181-6

Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21228, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/b:acli.0000008171.90644.f8DOI Listing
August 2004

Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia.

J Nerv Ment Dis 2003 Sep;191(9):563-7

Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.nmd.0000087181.61164.e1DOI Listing
September 2003

Perception of depot antipsychotics by mental health professionals.

J Psychiatr Pract 2003 May;9(3):252-60

University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00131746-200305000-00011DOI Listing
May 2003